LABT — Lakewood-amedex Biotherapeutics Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:02 PM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Lakewood-Amedex Announces 1-For-10 Reverse Stock Split Of Common Stock
Brief: Lakewood-Amedex Biotherapeutics Announces Positive Data For The Advancement Of Lead Candidate, Nu-3
Brief: Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3
Brief: Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data For Lead Candidate Targeting Infected Diabetic Foot Ulcers
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM